|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
4.100 +0.080 (+1.990%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,195,123 | 863,588 | 710,430 | 643,688 |
| Net Cash from / (used in) Investing Activities | -- | (2,622,095) | (494,021) | (1,936,045) | 60,365 |
| Net Cash from / (used in) Financing Activities | -- | (437,083) | (223,691) | 845,956 | (7,382) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,864,055) | 145,876 | (379,659) | 696,671 |
| Cash & Cash Equivalents at beginning of period | -- | 3,100,011 | 2,951,401 | 2,701,370 | 2,006,220 |
| Effect of Foreign Exchange Rate Changes | -- | 141 | 2,734 | 2,340 | (1,521) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,236,097 | 3,100,011 | 2,324,051 | 2,701,370 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 433,949 |
| %Change | 9.121% |
| EPS / (LPS) | RMB 0.340 |
| NBV Per Share (¥) | RMB 4.758 |